Early Clinical Data Support ex vivo Hematopoietic Stem Cell Gene Therapy as a Potentially Promising Treatment Option for X-CGD BOSTON and LONDON, Jan. 29, 2020 [...]
London, 24 January 2020 SmartTarget Ltd, a spinout company of UCL which successfully brought to market image fusion technology allowing accurate targeting of pr [...]
Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, has announced Syncona Ltd (Syncona) has made an $ [...]
Abcam plc, a global innovator in life science reagents and tools, and SomaServe Ltd, a Pharma service and specialist reagent business exploiting PolyNaut® Techn [...]
LONDON, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation program [...]
Somaserve Ltd, a newly founded UCLB spinout company from the UCL department of Chemistry, today announced that it has secured the IP and global commercial right [...]
Revolutionary technology developed at UCL Engineering that guides surgeons performing biopsies and improves prostate cancer detection has been featured on CBS [...]
AI spinout Hazy, featured in a recent Forbes list selecting the 15 Machine Learning Companies to Watch in Europe. Hazy made the top 10, for its platform that al [...]
Simon Goldman and David Grimm, who are responsible for managing investments for the UCL Technology Fund, the fund co-managed by UCLB and Albion Capital, have to [...]
UCLTF investment manager David Grimm recently spoke to Global University Venturing editor Thierry Heles to explain more about how the Fund is investing in UCL t [...]
